Belmont, MA, United States of America

Shuyi Tang


 

Average Co-Inventor Count = 11.9

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Quincy, MA (US) (2012)
  • Belmont, MA (US) (2012 - 2016)

Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Shuyi Tang

Introduction

Shuyi Tang is a prominent inventor based in Belmont, MA, known for his significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Tang has made remarkable strides in developing compounds that target critical pathways in cancer treatment.

Latest Patents

Among his latest innovations are compounds that act as ERK inhibitors. These compounds, characterized by a pyrazolopyridine base structure, have been disclosed along with methods for treating cancer using these innovative formulations. Additionally, Tang has developed pyrazolo[1,5-a]pyrimidine compounds that serve as mTOR inhibitors. These compounds are designed to address diseases where mTOR is deregulated, showcasing their potential in cancer therapy and other related disorders.

Career Highlights

Shuyi Tang is currently associated with Merck Sharp & Dohme Corporation, where he continues to advance his research and development efforts. His work is pivotal in the ongoing battle against cancer, contributing to the discovery of new therapeutic options.

Collaborations

Tang collaborates with esteemed colleagues, including Lianyun Zhao and M Arshad Siddiqui, who contribute to the innovative research environment that fosters groundbreaking discoveries.

Conclusion

Shuyi Tang's work exemplifies the spirit of innovation in the pharmaceutical industry, particularly in the development of targeted cancer therapies. His contributions are vital in the quest for effective treatments, and his ongoing research promises to yield further advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…